Compare ADIL & MRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ADIL | MRM |
|---|---|---|
| Founded | 2010 | 2000 |
| Country | United States | Japan |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Consumer Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.3M | 7.6M |
| IPO Year | 2017 | 2020 |
| Metric | ADIL | MRM |
|---|---|---|
| Price | $4.99 | $1.08 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $37.50 | N/A |
| AVG Volume (30 Days) | ★ 61.8K | 20.3K |
| Earning Date | 05-13-2026 | 05-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $32.01 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.13 | $0.83 |
| 52 Week High | $5.17 | $4.45 |
| Indicator | ADIL | MRM |
|---|---|---|
| Relative Strength Index (RSI) | 65.51 | 61.88 |
| Support Level | $2.38 | $1.07 |
| Resistance Level | $5.08 | $1.29 |
| Average True Range (ATR) | 0.50 | 0.07 |
| MACD | 0.04 | 0.02 |
| Stochastic Oscillator | 75.79 | 100.00 |
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its investigational new drug candidate, AD04, is being developed as a therapeutic agent for the treatment of alcohol use disorder. The company operates as one operating segment with a focus on drug development for addiction and related disorders.
MEDIROM Healthcare Technologies Inc provides health services. The company is a franchiser and operator of healthcare salons and operates in segments namely Relaxation Salon, Digital Preventative Healthcare, and Luxury Beauty Segment. The company generates a majority of its revenue from the Relaxation Salon business segment. Geographically, the company generates a maximum share of its revenue from Japan.